Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Net Income (2019 - 2026)

Alx Oncology Holdings' Net Income history spans 5 years, with the latest figure at $91.1 million for Q4 2023.

  • On a quarterly basis, Net Income rose 28.49% to $91.1 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$24.7 million, a 12.83% decrease, with the full-year FY2025 number at -$497000.0, up 99.63% from a year prior.
  • Net Income hit $91.1 million in Q4 2023 for Alx Oncology Holdings, up from -$51.0 million in the prior quarter.
  • Over the last five years, Net Income for ALXO hit a ceiling of $91.1 million in Q4 2023 and a floor of -$51.0 million in Q3 2023.
  • Historically, Net Income has averaged -$6.5 million across 5 years, with a median of -$11.3 million in 2020.
  • Biggest five-year swings in Net Income: tumbled 234.46% in 2020 and later soared 3265.38% in 2022.
  • Tracing ALXO's Net Income over 5 years: stood at -$7.8 million in 2019, then soared by 322.41% to $17.3 million in 2020, then tumbled by 87.8% to $2.1 million in 2021, then soared by 3265.38% to $70.9 million in 2022, then grew by 28.49% to $91.1 million in 2023.
  • Business Quant data shows Net Income for ALXO at $91.1 million in Q4 2023, -$51.0 million in Q3 2023, and -$34.5 million in Q2 2023.